user avatar
Tauseef Ali MD, FACG AGAF FACP
@ibdtweets
Gastroenterologist | IBD Expert | Founder, HLB™ | Creator, IBD Library™ | SSM Health IBD Center | Author | ACG Institute BOD
Oklahoma, USA 🇺🇸
ssmhealth.com/ibdcare
Joined December 2011
1,414
Following
10.7K
Followers
Posts
  • Pinned
    user avatar
    Tauseef Ali MD, FACG AGAF FACP
    @ibdtweets
    Nov 4, 2025
    Truly honored to be recognized as a 2025 Social Media Influencer by Healio Disruptive Innovators in collaboration with Healio Community. Social media has evolved into a powerful tool for medical education — a place to learn, teach, connect, and advocate. For me, it’s about
    3.9K
  • user avatar
    Tauseef Ali MD, FACG AGAF FACP
    @ibdtweets
    Oct 15, 2022
    First copy of my book landed! A book written with passion, enthusiasm. Dedicating to all my patients who taught me alot during their journey with this illness. Thanks @IBDMD for foreward and @ibdgijami for technical edition @CrohnsColitisFn @AmerGastroAssn @AmCollegeGastro
  • user avatar
    Tauseef Ali MD, FACG AGAF FACP
    @ibdtweets
    Aug 29, 2024
    IL-23 inhibitors can significantly improve Crohn's colitis, leading to remarkable bowel healing. This promising advance brings hope for better long-term outcomes in Crohn's disease.
    16K
  • user avatar
    Tauseef Ali MD, FACG AGAF FACP
    @ibdtweets
    Apr 4, 2022
    Finally a dream coming true! Official launch of our comprehensive Crohn’s and Colitis Center with many services under one roof ! For the patients. Ladies and gentlemen, I present to you our newly established Crohn’s and Colitis Center. Many more good news to come in future.
    user avatar
    SSM Health St. Anthony Hospital
    @SSMHealthSaints
    Apr 4, 2022
    Crohn’s and Colitis can be overwhelming. At our new Crohn’s & Colitis Center, nationally respected inflammatory bowel disease (IBD) specialists (like @IBDTweets) are here to help. Learn more at youtu.be/W3kyNkRPlZM.
  • user avatar
    Tauseef Ali MD, FACG AGAF FACP
    @ibdtweets
    Oct 27, 2024
    Don't under-treat moderate to severe UC patients.#ACG2024
    20K
  • user avatar
    Tauseef Ali MD, FACG AGAF FACP
    @ibdtweets
    Nov 11, 2021
    A very humbling experience, and thankful to all support of my family, friends and colleagues. I dedicate this award to all my patients !! 🙏
    user avatar
    SSM Health St. Anthony Hospital
    @SSMHealthSaints
    Nov 11, 2021
    Congrats to Tauseef Ali, MD, gastroenterologist, recipient of the 2021 St. Luke Award! The award is given each year by St. Anthony Hospital executives to the physician who most exemplifies the life of St. Luke, The Patron Saint of Physicians & Surgeons. #saintsinaction @ibdtweets
  • user avatar
    Tauseef Ali MD, FACG AGAF FACP
    @ibdtweets
    Apr 3, 2024
    I am truly honored by my patients and colleagues to receive this award. A very humbling experience! I dedicate this ward to my beloved IBD patients ❤️ Thank you, @CrohnsColitisFn, for supporting and advocating for IBD patients @SSMHealthSaints @SSMHealth
    11K
  • user avatar
    Tauseef Ali MD, FACG AGAF FACP
    @ibdtweets
    Sep 18, 2022
    Proudly presenting 2nd Ed Crohn’s and Colitis for Dummies. A book written for patients, friends, families and caregivers with updated chapter contents. Many thanks to @ibdgijami as technical editor and gratitude to @IBDMD for writing Foreward #1 New Release in Gastroenterology
  • user avatar
    Tauseef Ali MD, FACG AGAF FACP
    @ibdtweets
    Nov 19, 2023
    Know your mesalamine! A quick guide to mesalamine for UC in IBD #ibd101
    14K
  • user avatar
    Tauseef Ali MD, FACG AGAF FACP
    @ibdtweets
    Jun 21, 2025
    Fecal Calprotectin 101 by @MaiaKayalMD during #aibdregionals25 @AmCollegeGastro
    10K
  • user avatar
    Tauseef Ali MD, FACG AGAF FACP
    @ibdtweets
    May 17, 2025
    Fibrostenosing Crohn’s disease is a tough challenge 🔗10% of patients present with fibrosis at diagnosis 🔗50% develop strictures over time 🔗70% need surgery — and many redevelop disease post-op The cause? Still unclear. But scientists are digging into ECM expansion and
    7.8K
  • user avatar
    Tauseef Ali MD, FACG AGAF FACP
    @ibdtweets
    Jan 2, 2021
    STRIDE-II: Here is a slide summary of Crohn's Disease Targets @IbdClub. By @IOIBD1 @IBDMD @ibddocmaria et al An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the … pubmed.ncbi.nlm.nih.gov/33359090/
  • user avatar
    Tauseef Ali MD, FACG AGAF FACP
    @ibdtweets
    Jun 28, 2021
    NEW @AmCollegeGastro C DIFF Guidelines. Lets compare with older 2013's one ! Well we got the name change to begin with. Its Clost-tri-diodes Difficile now! @AmJGastro @DrStollman @DrJessicaA @gastrogirl @gastroendonews @HealioGastro @ibdclub
  • user avatar
    Tauseef Ali MD, FACG AGAF FACP
    @ibdtweets
    Jun 1, 2025
    ✅ Vedolizumab: Summary of Key Clinical Trials 🔹 GEMINI 1 & 2 IV vedolizumab is effective for: – UC: Strong induction & maintenance – CD: Modest induction, robust maintenance 🔹 EARNEST 📊 First RCT showing efficacy in chronic pouchitis, supporting post-IPAA use. 🔹 REPREVIO 🔁
    6.7K